Congenix joins Health Decisions’ global trial network
Russia-based CRO Congenix has joined Health Decisions’ Agile Clinical Network, expanding the group’s geographic reach.
Health Decisions established the network to help build partnerships with contract research organisations (CRO) in different regions and spread its methodology of adaptive operations.
The latest CRO to join the group is Moscow, Russia-based Congenix. Having completed the training programme Congenix has joined the network and will now conduct global clinical trials in conjunction with other group members.
Vladimir Novakovskiy, managing director, clinical operations and regulatory affairs, Congenix, added: “Conducting global, multi-center trials with a network of regionally focused CROs offers many advantages over a single large CRO with international offices.”
